{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:50:45Z","timestamp":1791827445491,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"DOI":"10.1007\/s12149-026-02300-2","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:26:03Z","timestamp":1791825963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glass versus resin microspheres in \u2079\u2070Y radioembolization for hepatocellular carcinoma: toxicity patterns under uniform voxel-based dosimetry"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4198-4416","authenticated-orcid":false,"given":"Ali","family":"Dablan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0646-7839","authenticated-orcid":false,"given":"Enes Mustafa","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3328-8173","authenticated-orcid":false,"given":"Meryem","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2858-0804","authenticated-orcid":false,"given":"Emrah","family":"Birol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2869-6842","authenticated-orcid":false,"given":"\u00c7a\u011fr\u0131","family":"Erdim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4361-5817","authenticated-orcid":false,"given":"Mustafa Fatih","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6937-2692","authenticated-orcid":false,"given":"Mehmet","family":"Cing\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7617-6125","authenticated-orcid":false,"given":"O\u011fuzhan","family":"T\u00fcrksayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5293-6407","authenticated-orcid":false,"given":"Cihan","family":"\u015ein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6631-7762","authenticated-orcid":false,"given":"Halil Burak","family":"Kapucu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4183-5824","authenticated-orcid":false,"given":"\u0130pek Kerimel","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2621-5070","authenticated-orcid":false,"given":"\u0130lker Mahmut","family":"Kayao\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5330-169X","authenticated-orcid":false,"given":"Tevfik","family":"G\u00fczelbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6623-1600","authenticated-orcid":false,"given":"Burcu Esen","family":"Akka\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"issue":"1","key":"2300_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7(1):6.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"2300_CR2","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1002\/cam4.5125","volume":"12","author":"AM Brown","year":"2023","unstructured":"Brown AM, Kassab I, Massani M, Townsend W, Singal AG, Soydal C, et al. TACE versus TARE for patients with hepatocellular carcinoma: overall and individual patient-level meta-analysis. Cancer Med. 2023;12(3):2590\u20139.","journal-title":"Cancer Med"},{"issue":"1","key":"2300_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1055\/s-2006-939842","volume":"23","author":"RJ Lewandowski","year":"2006","unstructured":"Lewandowski RJ, Salem R. Yttrium-90 radioembolization of hepatocellular carcinoma and metastatic disease to the liver. Semin Intervent Radiol. 2006;23(1):64\u201372.","journal-title":"Semin Intervent Radiol"},{"issue":"7","key":"2300_CR4","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00270-017-1594-4","volume":"40","author":"JR Kallini","year":"2017","unstructured":"Kallini JR, Gabr A, Thorlund K, et al. Comparison of the adverse event profile of TheraSphere\u00ae with SIR-Spheres\u00ae for the treatment of unresectable hepatocellular carcinoma: a systematic review. Cardiovasc Intervent Radiol. 2017;40(7):1033\u201343. https:\/\/doi.org\/10.1007\/s00270-017-1594-4.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2300_CR5","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1055\/s-0040-1720954","volume":"37","author":"A Villalobos","year":"2020","unstructured":"Villalobos A, Soliman MM, Majdalany BS, et al. Yttrium-90 radioembolization dosimetry: what trainees need to know. Semin Intervent Radiol. 2020;37:543\u201354.","journal-title":"Semin Intervent Radiol"},{"issue":"8","key":"2300_CR6","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1007\/s00330-015-4076-6","volume":"26","author":"CC Pieper","year":"2016","unstructured":"Pieper CC, Willinek WA, Thomas D, Ahmadzadehfar H, Essler M, Nadal J, et al. Incidence and risk factors of early arterial blood flow stasis during first radioembolization of primary and secondary liver malignancy using resin microspheres: an initial single-center analysis. Eur Radiol. 2016;26(8):2779\u201389.","journal-title":"Eur Radiol"},{"issue":"Suppl 1","key":"2300_CR7","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1002\/lt.20036","volume":"10","author":"BI Carr","year":"2004","unstructured":"Carr BI. Hepatic arterial yttrium-90 glass microspheres (TheraSphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transpl. 2004;10(Suppl 1):S107\u201310.","journal-title":"Liver Transpl"},{"issue":"10","key":"2300_CR8","first-page":"1673","volume":"41","author":"JE Dancey","year":"2000","unstructured":"Dancey JE, Shepherd FA, Paul K, Sniderman KW, Houle S, Gabrys J, et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic yttrium-90 microspheres. J Nucl Med. 2000;41(10):1673\u201381.","journal-title":"J Nucl Med"},{"issue":"Suppl 1","key":"2300_CR9","doi-asserted-by":"publisher","first-page":"S194","DOI":"10.1053\/j.gastro.2004.09.034","volume":"127","author":"JF Geschwind","year":"2004","unstructured":"Geschwind JF, Salem R, Carr BI, Soulen MC, Thurston KG, Goin KA, et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology. 2004;127(Suppl 1):S194\u2013205.","journal-title":"Gastroenterology"},{"issue":"1","key":"2300_CR10","first-page":"49","volume":"3","author":"J Goin","year":"2004","unstructured":"Goin J, Roberts C, Dancey J, Sickles C, Leung D, Soulen M. Comparison of postembolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: transcatheter arterial chemoembolization versus yttrium-90 glass microspheres. World J Nucl Med. 2004;3(1):49\u201356.","journal-title":"World J Nucl Med"},{"issue":"7","key":"2300_CR11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/jso.20609","volume":"94","author":"LM Kulik","year":"2006","unstructured":"Kulik LM, Atassi B, van Holsbeeck L, Souman T, Lewandowski RJ, Mulcahy MF, et al. Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol. 2006;94(7):572\u201386.","journal-title":"J Surg Oncol"},{"issue":"3","key":"2300_CR12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0360-3016(97)00818-3","volume":"40","author":"WY Lau","year":"1998","unstructured":"Lau WY, Ho S, Leung TW, Chan M, Ho R, Johnson PJ, et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of yttrium-90 microspheres. Int J Radiat Oncol Biol Phys. 1998;40(3):583\u201392.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2300_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","volume":"138","author":"R Salem","year":"2010","unstructured":"Salem R, Lewandowski RJ, Mulcahy MF, Riaz A, Ryu RK, Ibrahim S, et al. Radioembolization for hepatocellular carcinoma using yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology. 2010;138(1):52\u201364.","journal-title":"Gastroenterology"},{"issue":"3","key":"2300_CR14","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/hep.24451","volume":"54","author":"B Sangro","year":"2011","unstructured":"Sangro B, Carpanese L, Cianni R, Golfieri R, Gasparini D, Ezziddin S, et al. Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona Clinic Liver Cancer stages: a European evaluation. Hepatology. 2011;54(3):868\u201378.","journal-title":"Hepatology"},{"issue":"3","key":"2300_CR15","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ijrobp.2006.05.065","volume":"66","author":"B Sangro","year":"2006","unstructured":"Sangro B, Bilbao JI, Boan J, Martinez-Cuesta A, Benito A, Rodriguez J, et al. Radioembolization using yttrium-90 resin microspheres for patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2006;66(3):792\u2013800.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"2300_CR16","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jvir.2010.04.012","volume":"21","author":"M Inarrairaegui","year":"2010","unstructured":"Inarrairaegui M, Thurston KG, Bilbao JI, D\u2019Avola D, Rodriguez M, Arbizu J, et al. Radioembolization with yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol. 2010;21(8):1205\u201312.","journal-title":"J Vasc Interv Radiol"},{"issue":"11","key":"2300_CR17","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1177\/000313480407001103","volume":"70","author":"MD Liu","year":"2004","unstructured":"Liu MD, Uaje MB, Al-Ghazi MS, Fields D, Herman J, Kuo JV, et al. Use of yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma. Am Surg. 2004;70(11):947\u201353.","journal-title":"Am Surg"},{"issue":"7","key":"2300_CR18","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jvir.2023.02.030","volume":"34","author":"A Villalobos","year":"2023","unstructured":"Villalobos A, Arndt L, Cheng B, et al. Yttrium-90 radiation segmentectomy of hepatocellular carcinoma: a comparative study of the effectiveness, safety, and dosimetry of glass-based versus resin-based microspheres. J Vasc Interv Radiol. 2023;34(7):1226\u201334. https:\/\/doi.org\/10.1016\/j.jvir.2023.02.030.","journal-title":"J Vasc Interv Radiol"},{"issue":"6","key":"2300_CR19","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s00259-023-06111-9","volume":"50","author":"N Kokabi","year":"2023","unstructured":"Kokabi N, Arndt-Webster L, Chen B, et al. Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based yttrium-90 radioembolization: a prospective, single-arm study. Eur J Nucl Med Mol Imaging. 2023;50(6):1743\u201352. https:\/\/doi.org\/10.1007\/s00259-023-06111-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"2300_CR20","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s00270-022-03215-x","volume":"45","author":"E Garin","year":"2022","unstructured":"Garin E, Guiu B, Edeline J, Rolland Y, Palard X. Trans-arterial radioembolization dosimetry in 2022. Cardiovasc Intervent Radiol. 2022;45(11):1608\u201321. https:\/\/doi.org\/10.1007\/s00270-022-03215-x.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2300_CR21","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE), version 5.0. 2018. Available from: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf. Accessed 2023 Apr 13."},{"issue":"4","key":"2300_CR22","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s00270-005-0171-4","volume":"29","author":"K Sato","year":"2006","unstructured":"Sato K, Lewandowski RJ, Bui JT, Omary R, Hunter RD, Kulik L, et al. Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol. 2006;29(4):522\u20139.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"4","key":"2300_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00270-007-9064-z","volume":"30","author":"RJ Lewandowski","year":"2007","unstructured":"Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA Jr, Kulik L, et al. Radioembolization with yttrium-90 microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol. 2007;30(4):571\u201392.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"Suppl 1","key":"2300_CR24","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1148\/rg.25si055515","volume":"25","author":"R Murthy","year":"2005","unstructured":"Murthy R, Nunez R, Szklaruk J, Erwin W, Madoff DC, Gupta S, et al. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications. Radiographics. 2005;25(Suppl 1):S41\u201355.","journal-title":"Radiographics"},{"issue":"9","key":"2300_CR25","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1097\/01.RVI.0000235779.88652.53","volume":"17","author":"R Salem","year":"2006","unstructured":"Salem R, Thurston KG. Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol. 2006;17(9):1425\u201339.","journal-title":"J Vasc Interv Radiol"},{"issue":"Suppl","key":"2300_CR26","first-page":"S2","volume":"15","author":"C Nutting","year":"2004","unstructured":"Nutting C, Coldwell D, Jones B, Quarnberg D. Coil embolization prevents GI ulcers during yttrium-90 hepatic radioembolization. J Vasc Interv Radiol. 2004;15(Suppl):S2.","journal-title":"J Vasc Interv Radiol"},{"issue":"13","key":"2300_CR27","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1007\/s00259-025-07334-8","volume":"52","author":"MGEH Lam","year":"2025","unstructured":"Lam MGEH, Garin E, Fowers KD, Mahvash A, Padia SA, Salem R. The relationship between yttrium-90 glass microspheres specific activity, particle density and treatment outcomes in HCC and mCRC. Eur J Nucl Med Mol Imaging. 2025;52(13):4834\u201346. https:\/\/doi.org\/10.1007\/s00259-025-07334-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"2300_CR28","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.3390\/molecules26133966","volume":"26","author":"P d\u2019Abadie","year":"2021","unstructured":"d\u2019Abadie P, Hesse M, Louppe A, Lhommel R, Walrand S, Jamar F. Microspheres used in liver radioembolization: from conception to clinical effects. Molecules. 2021;26(13):3966. https:\/\/doi.org\/10.3390\/molecules26133966.","journal-title":"Molecules"},{"issue":"10","key":"2300_CR29","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1007\/s00259-022-05774-0","volume":"49","author":"M Lam","year":"2022","unstructured":"Lam M, Garin E, Maccauro M, et al. A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with yttrium-90: the TARGET study. Eur J Nucl Med Mol Imaging. 2022;49(10):3340\u201352. https:\/\/doi.org\/10.1007\/s00259-022-05774-0.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"2300_CR30","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","volume":"76","author":"M Reig","year":"2022","unstructured":"Reig M, Forner A, Rimola J, Ferrer-F\u00e0brega J, Burrel M, Garcia-Criado \u00c1, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol. 2022;76(3):681\u201393. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.018.","journal-title":"J Hepatol"},{"key":"2300_CR31","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fonc.2014.00198","volume":"4","author":"A Riaz","year":"2014","unstructured":"Riaz A, Awais R, Salem R. Side effects of yttrium-90 radioembolization. Front Oncol. 2014;4:198. https:\/\/doi.org\/10.3389\/fonc.2014.00198.","journal-title":"Front Oncol"},{"issue":"12","key":"2300_CR32","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1097\/01.RVI.0000184594.01661.81","volume":"16","author":"R Salem","year":"2005","unstructured":"Salem R, Lewandowski RJ, Atassi B, Gordon SC, Gates VL, Barakat O, et al. Treatment of unresectable hepatocellular carcinoma with yttrium-90 microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol. 2005;16(12):1627\u201339. https:\/\/doi.org\/10.1097\/01.RVI.0000184594.01661.81.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"2300_CR33","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00270-013-0742-8","volume":"37","author":"MG Lam","year":"2014","unstructured":"Lam MG, Banerjee A, Louie JD, Sze DY. Splenomegaly-associated thrombocytopenia after hepatic yttrium-90 radioembolization. Cardiovasc Intervent Radiol. 2014;37(4):1009\u201317. https:\/\/doi.org\/10.1007\/s00270-013-0742-8.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"10","key":"2300_CR34","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1097\/MNM.0000000000001439","volume":"42","author":"SC Kappadath","year":"2021","unstructured":"Kappadath SC, Lopez BP, Salem R, Lam MGEH. Reassessment of the lung dose limits for radioembolization. Nucl Med Commun. 2021;42(10):1064\u201375. https:\/\/doi.org\/10.1097\/MNM.0000000000001439.","journal-title":"Nucl Med Commun"},{"issue":"5","key":"2300_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/COC.0b013e318168ef65","volume":"31","author":"R Salem","year":"2008","unstructured":"Salem R, Parikh P, Atassi B, Lewandowski RJ, Ryu RK, Sato KT, et al. Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution. Am J Clin Oncol. 2008;31(5):431\u20138.","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"2300_CR36","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00259-019-04517-y","volume":"47","author":"A Das","year":"2020","unstructured":"Das A, Riaz A, Gabr A, Ali R, Mora R, Al Asadi A, et al. Safety and efficacy of radioembolization with glass microspheres in hepatocellular carcinoma patients with elevated lung shunt fraction: analysis of a 103-patient cohort. Eur J Nucl Med Mol Imaging. 2020;47(4):807\u201315.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2300_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jvir.2024.08.031","volume":"36","author":"B Kis","year":"2025","unstructured":"Kis B, Gyano M. Radiation pneumonitis after yttrium-90 radioembolization: a systematic review. J Vasc Interv Radiol. 2025;36:207\u201318. https:\/\/doi.org\/10.1016\/j.jvir.2024.08.031.","journal-title":"J Vasc Interv Radiol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02300-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-026-02300-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-026-02300-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:26:05Z","timestamp":1791825965000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-026-02300-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":37,"alternative-id":["2300"],"URL":"https:\/\/doi.org\/10.1007\/s12149-026-02300-2","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"20 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the institutional review board (Protocol No. 25.09.2024-224) and was conducted in accordance with institutional and ethical standards.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients included in the study.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}